| Safeway Pharmacy #1485 | |
| 1258 State Ave, Marysville, Washington 98270 | |
| (360) 659-2882 |
| Name | Safeway Pharmacy #1485 |
|---|---|
| Organization Name | Safeway Inc |
| Location | 1258 State Ave, Marysville, Washington 98270 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (360) 659-2882 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Of all gastrointestinal cancers, pancreatic cancer is one of the most aggressive. Because of this, it has a very low 5-year survival rate of just 5% and a median survival time below 6 months. Additionally, treatment is difficult, with only surgery shown to provide a cure. However, the vast majority of patients have tumors that cannot be removed surgically or their cancer is too advanced or spread too far to be treatable.
Johns Hopkins scientists report they have identified two potential new drug targets for the treatment of HIV. The finding is from results of a small, preliminary study of 19 people infected with both HIV-;the virus that causes AIDS-;and the hepatitis C virus.
Non-Invasive Monitoring Systems, Inc. announced that the Nogawa Patent Office in Japan issued Patent number 4391595 to NIMS on October 16, 2009. This patent, entitled "Reciprocating Movement Platform for Shifting Subject To and Fro In Headwards-Footwards Direction," relates to the comprehensively researched technology underlying NIMS' Exer-Rest acceleration therapeutic platform.
Breast Cancer Awareness Month raises visibility and research dollars to address a disease that in the United States claims nearly 40,000 lives annually and affects approximately 240,000 people who each year are newly diagnosed. While the month's activities are important in the fight against breast cancer, they are not designed to directly improve the day-to-day management of the disease.
Much of the devastation of stroke and head trauma is due to damage caused the overproduction of a substance in the brain called glutamate. Preventing this damage has been impossible, until now, as many drugs don't cross the so-called blood-brain barrier, and those that do often don't work as intended. But a method originally devised at the Weizmann Institute of Science may, in the future, offer a way to avert such glutamate-induced harm.
› Verified 9 days ago
| NPI Number | 1811926827 |
| Organization Name | SAFEWAY INC |
| Doing Business As | SAFEWAY PHARMACY #1485 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1258 State Ave, Marysville, WA 98270 |
| Phone Number | 360-659-2882 |
News Archive
Of all gastrointestinal cancers, pancreatic cancer is one of the most aggressive. Because of this, it has a very low 5-year survival rate of just 5% and a median survival time below 6 months. Additionally, treatment is difficult, with only surgery shown to provide a cure. However, the vast majority of patients have tumors that cannot be removed surgically or their cancer is too advanced or spread too far to be treatable.
Johns Hopkins scientists report they have identified two potential new drug targets for the treatment of HIV. The finding is from results of a small, preliminary study of 19 people infected with both HIV-;the virus that causes AIDS-;and the hepatitis C virus.
Non-Invasive Monitoring Systems, Inc. announced that the Nogawa Patent Office in Japan issued Patent number 4391595 to NIMS on October 16, 2009. This patent, entitled "Reciprocating Movement Platform for Shifting Subject To and Fro In Headwards-Footwards Direction," relates to the comprehensively researched technology underlying NIMS' Exer-Rest acceleration therapeutic platform.
Breast Cancer Awareness Month raises visibility and research dollars to address a disease that in the United States claims nearly 40,000 lives annually and affects approximately 240,000 people who each year are newly diagnosed. While the month's activities are important in the fight against breast cancer, they are not designed to directly improve the day-to-day management of the disease.
Much of the devastation of stroke and head trauma is due to damage caused the overproduction of a substance in the brain called glutamate. Preventing this damage has been impossible, until now, as many drugs don't cross the so-called blood-brain barrier, and those that do often don't work as intended. But a method originally devised at the Weizmann Institute of Science may, in the future, offer a way to avert such glutamate-induced harm.
› Verified 9 days ago
News Archive
Of all gastrointestinal cancers, pancreatic cancer is one of the most aggressive. Because of this, it has a very low 5-year survival rate of just 5% and a median survival time below 6 months. Additionally, treatment is difficult, with only surgery shown to provide a cure. However, the vast majority of patients have tumors that cannot be removed surgically or their cancer is too advanced or spread too far to be treatable.
Johns Hopkins scientists report they have identified two potential new drug targets for the treatment of HIV. The finding is from results of a small, preliminary study of 19 people infected with both HIV-;the virus that causes AIDS-;and the hepatitis C virus.
Non-Invasive Monitoring Systems, Inc. announced that the Nogawa Patent Office in Japan issued Patent number 4391595 to NIMS on October 16, 2009. This patent, entitled "Reciprocating Movement Platform for Shifting Subject To and Fro In Headwards-Footwards Direction," relates to the comprehensively researched technology underlying NIMS' Exer-Rest acceleration therapeutic platform.
Breast Cancer Awareness Month raises visibility and research dollars to address a disease that in the United States claims nearly 40,000 lives annually and affects approximately 240,000 people who each year are newly diagnosed. While the month's activities are important in the fight against breast cancer, they are not designed to directly improve the day-to-day management of the disease.
Much of the devastation of stroke and head trauma is due to damage caused the overproduction of a substance in the brain called glutamate. Preventing this damage has been impossible, until now, as many drugs don't cross the so-called blood-brain barrier, and those that do often don't work as intended. But a method originally devised at the Weizmann Institute of Science may, in the future, offer a way to avert such glutamate-induced harm.
› Verified 9 days ago
Sav-on Pharmacy #0471 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 301 Marysville Mall, Marysville, Washington 98270 Phone: (360) 659-8952 | |
Fred Meyer Paharmacy #209 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 9925 State Ave, Marysville, Washington 98270 Phone: (360) 653-0733 | |
Haggen Pharmacy #3604 Type: Pharmacy Location: 3711 88th St Ne, Marysville, Washington 98270 Phone: (360) 530-7761 | |
Safeway Pharmacy #1485 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1258 State Ave, Marysville, Washington 98270 Phone: (360) 659-2882 | |
Bartell Drugs #51 Type: Pharmacy Location: 6602 64th St Ne, Marysville, Washington 98270 Phone: (360) 658-5218 |